Carbapenems are β-lactam antibiotics used in healthcare settings as last resort drugs to treat infections caused by antibiotic-resistant bacteria. Carbapenem-resistant bacteria are increasingly being isolated from healthcare facilities; however, little is known about their distribution or prevalence in the environment, especially in the United States, where their distribution in water environments from the West Coast has not been studied before. The aim of this study was to determine the prevalence of carbapenem-resistant bacteria and carbapenemase genes in water bodies from the Los Angeles area (California, USA). All samples that were analyzed contained carbapenem-resistant bacteria with a frequency of between 0.1 and 324 carbapenemresistant cfu per 100 mls of water. We identified 76 carbapenem-resistant or -intermediate isolates, most of which were also resistant to noncarbapenem antibiotics, as different strains of Enterobacter asburiae, Aeromonas veronii, Cupriavidus gilardii, Pseudomonas, and Stenotrophomonas species. Of them, 52 isolates were carbapenemase-producers. Furthermore, PCR and sequence analysis to identify the carbapenemase gene of these carbapenemase-producing isolates revealed that all Enterobacter asburiae isolates had a bla IMI-2 gene 100% identical to the reference sequence, and all Stenotrophomonas maltophlia isolates had a bla L1 gene 83%-99% identical to the reference bla L1 . Our findings indicate that water environments in Southern California are an important reservoir of bacteria-resistant to carbapenems and other antibiotics, including bacteria carrying intrinsic and acquired carbapenemase genes.
| INTRODUC TI ON
are broad-spectrum β-lactam antibiotics. Unlike other β-lactams such as penicillins and cephalosporins, carbapenems are resistant to hydrolysis by β-lactamases and extended spectrum β-lactamases (Martin & Kaye, 2004; Papp-Wallace, Endimiani, Taracila, & Bonomo, 2011; Vardakas, Tansarli, Rafailidis, & Falagas, 2012) . The use of carbapenems is generally restricted to hospitals and other healthcare settings, where they are used as last resort drugs to treat serious infections caused by antibiotic-resistant bacteria (Bradley et al., 1999; Papp-Wallace et al., 2011; Paterson, 2000 Paterson, , 2002 Paterson & Bonomo, 2005; Torres, Villegas, & Quinn, 2007) .
Carbapenem-resistant bacteria represent a major challenge to public health. These bacteria are primarily considered as nosocomial pathogens Bratu, Mooty, et al., 2005 ; Centers for Disease Control and Prevention, 2013a), and their isolation in healthcare settings is on the rise (Centers for Disease Control and Prevention, 2018; Correa et al., 2012; Cuzon et al., 2011; Guh et al., 2015; Gupta, Limbago, Patel, & Kallen, 2011; Kallen, Hidron, Patel, & Srinivasan, 2010; Khuntayaporn, Montakantikul, Mootsikapun, Thamlikitkul, & Chomnawang, 2012; Prabaker & Weinstein, 2011; Queenan et al., 2012; Rhomberg & Jones, 2009; Rizek et al., 2014; Rodríguez-Martínez, Poirel, & Nordmann, 2009; van Duijn, Dautzenberg, & Oostdijk, 2011; Viehman, Nguyen, & Doi, 2014) . For example, carbapenemresistant Enterobacteriaceae have been designated as an urgent threat by the CDC (Centers for Disease Control and Prevention, 2013a, 2013b) and are associated with very high mortality rates (Papp-Wallace et al., 2011; Paterson, 2000; van Duin, Kaye, Neuner, & Bonomo, 2013) . Likewise, Acinetobacter baumannii and Pseudomonas aeruginosa strains that are resistant to multiple antibiotics, including carbapenems, have been designated by the CDC as serious threats, and are often untreatable (Centers for Disease Control and Prevention, 2013a, 2013b) . Stenotrophomonas maltophilia, another hard-to-treat emerging pathogen that causes pneumonia and blood infections among other diseases (Brooke, 2012) , is usually resistant to most antibiotics, including carbapenems (Brooke, 2012; Yang et al., 2014) .
A variety of mechanisms can contribute to carbapenem resistance. These include decreased outer membrane permeability (Livermore, Mushtaq, & Warner, 2005; Rizek et al., 2014; Shin et al., 2012; Sho et al., 2013; Warner et al., 2013) , overexpression of efflux pumps or chromosomal β-lactamases (Papp-Wallace et al., 2011; Rodríguez-Martínez et al., 2009; Warner et al., 2013) , and production of carbapenemases, which are enzymes that degrade carbapenems and other β-lactams (Marsik & Nambiar, 2011; Queenan & Bush, 2007) . Carbapenemase production is especially worrisome because of the strong activity of these enzymes against carbapenems, and the fact that carbapenemase genes are frequently found in genetic mobile elements such as plasmids, which favors their spread (Mathers et al., 2011; Walsh, 2010) .
Despite their public health importance and increased incidence in healthcare facilities (Guh et al., 2015; Gupta et al., 2011; Papp-Wallace et al., 2011; Prabaker & Weinstein, 2011; Rhomberg & Jones, 2009; van Duijn et al., 2011) , knowledge about carbapenem-resistant bacteria and genes in the environment is very limited, especially in the United States. Most efforts to detect these bacteria have focused on healthcare (Conlan et al., 2014; Doi & Paterson, 2015; Guh et al., 2015; Gupta et al., 2011) or immediately related settings such as hospital wastewater (Chagas, Seki, da Silva, & Asensi, 2011; Nasri et al., 2017; White et al., 2016) .
However, recent findings in Europe, Africa and Asia have revealed carbapenem-resistant bacteria and genes in freshwater and other environmental samples (Di, Jang, Unno, & Hur, 2017; Girlich, Poirel, & Nordmann, 2010; Henriques et al., 2012; Isozumi et al., 2012; Poirel et al., 2012; Potron, Poirel, Bussy, & Nordmann, 2011; Tacão, Correia, & Henriques, 2015; Zurfluh, Hachler, Nuesch-Inderbinen, & Stephan, 2013) .
In the United States, carbapenem-resistant bacteria were isolated from 7 out of 16 rivers from the Midwest sampled between 1999 and 2001 (Ash, Mauck, & Morgan, 2002; Aubron, Poirel, Ash, & Nordmann, 2005) . To this date, this study remains the only specific analysis about the distribution and characteristics of carbapenem-resistant bacteria in water environments not directly related to healthcare facilities in the United States. Given the importance of carbapenem-resistant bacteria, further studies on other areas of the United States and on different types of aquatic environments, are needed to gain a better understanding of the environmental distribution and molecular mechanisms of carbapenem-resistant bacteria in the United States. To contribute to address this gap in knowledge, we report here the first study about the distribution and characteristics of carbapenem-resistant bacteria and carbapenemase genes in aquatic environments on the West Coast of the United States, as well as the first study about these bacteria and genes in ponds and lakes in the United States.
All samples analyzed contained carbapenem-resistant bacteriamost of which were also resistant to other antibiotics -which we identified as Enterobacter, Aeromonas, Cupriavidus, Pseudomonas or Stenotrophomonas species. Many of the carbapenem-resistant isolates further characterized carried a carbapenemase gene. These findings suggest that carbapenem-resistant bacteria and carbapenemase genes are widely distributed on diverse water environments on the West Coast of the United States.
| MATERIAL S AND ME THODS

| Sample collection and isolation of carbapenem-resistant bacteria
We collected 10 different water samples from ponds and lakes Table 1 . Four liters of surface-level water were collected in sterile bottles and immediately transported to the laboratory. The total count of gramnegative bacteria was determined by direct plating 100 μl of water (and also by spot plating 10 μl of a 10 0 to 10 -4 dilution bank of each sample in sterile water) on MacConkey agar (Fisher Scientific, Hampton, NH) plates, followed by incubation in aerobic conditions for 24 hr at 37°C, and colony counting. The count of carbapenem-resistant gram-negatives was determined by the same procedure except for using MacConkey agar plates supplemented with 4 μg/ml of meropenem (Ark Pharm, Inc., Arlington Heights, IL), which is the meropenem minimum inhibitory con- Because several species of the genera Pseudomonas and Stenotrophomonas are closely related and are difficult to distinguish based only on their 16S rDNA sequences, isolates in which their 16S rDNA closely matched both genera were further identified using the oxidase test. This test detects the production of the cytochrome C oxidase enzyme, and is positive for Pseudomonas and negative for Stenotrophomonas (Bergey & Holt, 1994) . The and E. coli BW25113 were used as our positive and negative controls, respectively.
| Determination of the antibiotic susceptibility profile of carbapenem-resistant isolates
Determination of the antibiotic susceptibility profile for carbapenems and other antibiotics ( Table 2; Table 3 
| Identification of carbapenemase-producing isolates by the CarbaNP assay
We used the CarbaNP assay (Dortet, Poirel, & Nordmann, 2012a , 2012b to identify which carbapenem-resistant isolates produced carbapenemases. The assay was performed as described by CLSI (Clinical and Laboratory Standards Institute, 2017) using 6 mg/ml of either meropenem or imipenem, and using colonies from isolates grown overnight at 37°C on Mueller-Hinton agar without (to detect for noninducible carbapenemases) or with (to detect for carbapenem-inducible carbapenemases) meropenem at 4 or 16 μg/ml. Isolates that hydrolyzed meropenem and/or imipenem, and thus turned yellow at 37°C within 2 hr, but did not turn yellow in the absence of meropenem or imipenem, were considered positive for carbapenemase production.
Carbapenemase production was considered carbapenem-inducible when the CarbaNP test was positive only when using cells grown in
Mueller-Hinton-meropenem plates.
TA B L E 1 Summary of the origin, total gram-negative and carbapenem-resistant gram-negative bacterial counts obtained in this study We obtained two water samples from this artificial pond, one before (June of 2016) and one after (August 2016) it was cleaned and the waterpumping system fixed. This artificial pond uses circulation of potable water. b Lake Balboa and Woodley Wildlife Lake are filled with reclaimed water from the Tillman Water Reclamation Plant (DCTWRP). Lake balboa is a recreational lake, and Woodley Wildlife lake is a wild wetland habitat with many species of birds. The water from the Tujunga Ponds Wildlife Sanctuary is spring water from the Tujunga Canyon delivered to the pond via a small stream. d Reseda Park Lake, Magic Johnson Park lake, and Rancho Simi Community Park Duck Pond use circulation of potable water. Reseda park lake is an asphalt-lined urban lake. e Malibu Creek Rock Pool is a natural pool filled with rain run-off.
| PCR, sequencing and phylogenetic analysis of carbapenemases
PCR amplification and sequencing of carbapenemases from
CarbaNP-positive isolates were performed as described in section 2.2, with the following modifications: We used the primers and PCR program described by Henriques et al. (2012) to amplify bla L1. To amplify bla IMI , we designed the primers Imi2-F1 (5'-CAA GTA GAA TAG CCA TCT TGT TTA G) and Imi2-R1 (5'-AGG TTA TCA ATT GCG ATT CTT G), which amplify 853 out of 870 bp of the bla IMI-1 (U50278) and bla IMI-2 (DQ173429) genes, and performed the PCR step using a Tm of 55°C and an extension time of 1 min. For each PCR, washed cells of strains carrying each bla gene were used as positive control, E. coli BW25113 was used as negative control, and DNA grade water was used as nontemplate control. We used Geneious R11 software to perform multiple sequence alignments (MUSCLE alignment tool) of the bla IMI-2 sequences obtained and the bla IMI-2 reference sequence (DQ173429), and of the bla L1 sequences obtained and the bla L1 reference sequence (NG_047502), as well as to build a bla L1 phylogenetic tree based on the Jukes-Cantor genetic distance model and the Neighbor-Joining method.
| Nucleotide accession numbers
All 16S rDNA, bla IMI-2 , and bla L1 sequences obtained in this study have been deposited in GenBank (https://www.ncbi.nlm.nih.gov/ genbank/) under the following accession numbers: MG905248-MG905292, MG905294-MG905307, MG905309-MG905321, and MH200608-MH200614 for 16SrDNA sequences, MH203307-MH203307 for bla IMI-2 , and MG882588-MG882609 and MG882611-MG882634 for bla L1 sequences .
| RE SULTS
| Distribution, frequency and identification of carbapenem-resistant gram-negative bacteria in water bodies in the Los Angeles area
We analyzed 10 different water samples from ponds and lakes in the Los Angeles area (California, United States) and found that all of them contained carbapenem (meropenem)-resistant gram-negative bacteria. The frequency of gram-negative meropenem-resistant bacteria was between 0.1 and 324 meropenem-resistant cfu per 100 mls of water, which represented between 0.002% and 0.8% of the total gram-negative bacteria found in these water samples (Table 1 ). The two samples with the highest count of meropenemresistant bacteria per 100 ml were W1 and W6. Location W1 (CSUN Duck pond) is an artificial pond with a large number of animals (ducks, geese and turtles) which uses circulated potable water.
However, the circulation system was not functioning at the time of sampling (the same location sampled after cleaning the pond and fixing the circulation system had more than a 10-fold decrease in the TA B L E 2 Number and characteristics of carbapenem-resistant isolates identified from water samples described in 
| Characterization of the antibiotic susceptibility profile of carbapenem-resistant isolates
We characterized the antibiotic susceptibility profile of the 76 identified carbapenem-resistant or -intermediate isolates using disk diffusion experiments with 2 carbapenems (meropenem and imipenem) and 4 non-carbapenem (cefotaxime, ciprofloxacin, gentamicin, and tetracycline) antibiotics (Table 2; Table 3 ; and Figure 2 Table 3 ; and Figure 2 ).
Overall, these findings highlight the importance of different aquatic environments in the Los Angeles-Southern California area as reservoirs of bacteria that are resistant to carbapenems and other antibiotics.
| Identification of carbapenemases from carbapenem-resistant isolates
We next used the CarbaNP test to identify which carbapenemresistant or -intermediate isolates produce carbapenemases. We found that 52 out of the 76 isolates studied were positive for carbapenemase production when tested using meropenem and/or imipenem ( Table 2; Table 3 ). CarbaNP-positive isolates included 7
E. asburiae and all 45 S. maltophilia. In all these isolates, their carbapenemases were inducible.
We then used PCR and sequencing to identify the carbapenemase genes present in the 52 CarbaNP-positive isolates (Table 2;   Table 3 ; and Figure 3 ). All seven E. asburiae isolates had a bla gene 100% identical to the bla IMI-2 reference sequence (DQ173429).
All 45 carbapenemase-producing S. maltophilia isolates had the bla L1 gene. Analysis of the bla L1 genes identified revealed that environmental L1 carbapenemases are very diverse. All bla L1 DNA sequences obtained for our isolates had between 83% to 99% identity to the reference S. maltophilia bla L1 gene (NG_047502) -a variability similar to that found in S. maltophilia clinical isolates (Avison, Higgins, von Heldreich, Bennett, & Walsh, 2001 ).
| D ISCUSS I ON
Carbapenem resistance is one of the major threats to public health by screening isolates first identified as ampicillin resistant (Ash et al., 2002; Aubron et al., 2005) , the frequency of carbapenem-resistant bacteria found in our study is similar to that found Tacão et al. (2015) in Portuguese rivers.
Characterization of a total of 76 isolates from these samples
showed Stenotrophomonas pavanii. These results have some similarities and differences with previous studies. The most abundant carbapenemresistant bacterium among our isolates (found in most of our samples) was S. maltophilia, which is common in aquatic environments and intrinsically resistant to carbapenems (Brooke, 2012) . However, we also found S. pavanii in the Tujunga pond (a natural pond filled with spring water). S. pavanii is a bacterium previously found in plants (Ramos et al., 2011) and in bird feces (Kenzaka & Tani, 2018) , which to our knowledge has not been found before in aquatic environments.
The second most abundant and widespread (present in most of our samples) group of carbapenem-resistant bacteria we found was
Pseudomonas. Interestingly, carbapenem-resistant Pseudomonas isolates (P. geniculata and P. otitidis among other Pseudomonas, but not P. cedrina or P. stutzeri) were also found to be abundant in Portuguese rivers (Tacão et al., 2015) , but were not found in the midwestern United States rivers (Aubron et al., 2005) . In contrast with the results for Pseudomonas, Enterobacter asburiae represented the most abundant and widespread (they were found in 4 different rivers)
carbapenem-resistant isolate found in rivers from the U.S. Midwest (Aubron et al., 2005) , but was only found in one sample both in the study of Portuguese rivers (Tacão et al., 2015) as well as in our study (Woodley Wildlife lake).
The other carbapenem-resistant or -intermediate isolates that
we found are Aeromonas veronii and Cupriavidus gilardii. Aeromonas, including A. veronii, are common water inhabitants and are often intrinsically resistant to carbapenems (Aubron et al., 2005; Lupo, Coyne, & Berendonk, 2012; Tacão et al., 2015) . In contrast, this is the first time that carbapenem-resistant C. gilardii isolates -which we identified in a location (W2) that uses recirculated potable waterhave been reported outside of clinical settings (Karafin et al., 2010; Kobayashi et al., 2016 (tetracycline) was widespread among our isolates, whereas resistance to fluoroquinolones (ciprofloxacin) was very rare among them.
Resistance to carbapenems can occur by different mechanisms such as production of carbapenemases, overexpression of efflux pumps, and decreased outer membrane permeability (Livermore et al., 2005; Marsik & Nambiar, 2011; Papp-Wallace et al., 2011; Queenan & Bush, 2007; Rizek et al., 2014; Rodríguez-Martínez et al., 2009; Shin et al., 2012; Sho et al., 2013; Warner et al., 2013) . Production of carbapenemases seems to be a major contributing mechanism for carbapenem-resistance in most of our isolates because 52 of the 76 isolates characterized were carbapenemase-producers. The carbapenemase gene of these carbapenemase-producing isolates was identified by PCR and sequencing as bla IMI-2 100% identical to the reference sequence for all Enterobacter asburiae isolates and as bla L1 for all Stenotrophomonas maltophilia isolates. The bla L1 carbapenemase genes identified showed varying diversity (83%-99% DNA identity) compared to the bla L1 reference sequence. The presence of the L1 carbapenemase in Stenotrophomonas maltophilia is well documented in both clinical and environmental isolates and is a major contributor to its untreatability (Brooke, 2012; Tacão et al., 2015; Youenou et al., 2015) .
Of greater concern is the identification of seven E. asburiae isolates carrying the bla IMI-2 carbapenemase gene. This gene is an inducible plasmid-encoded carbapenemase gene that was first identified in carbapenem-resistant E. asburiae isolates from four different U.S. Midwest rivers (Aubron et al., 2005) , and was later found in an Enterobacter cloacae isolate recovered from river sediment in Spain in 2017 (Piedra-Carrasco et al., 2017) . bla IMI-2 has also recently been found in clinical isolates of E. asburiae (Czech Republic) (Rotova et al., 2017) , E. cloacae (China) (Yu, Du, Zhou, Chen, & Li, 2006) , Escherichia coli (Spain and China) (Rojo-Bezares, Martin, Lopez, Torres, & Saenz, 2012; Zhang et al., 2017) , and
Klebsiella variicola (United Kingdom) (Hopkins, Findlay, Doumith, Mather, & Meunier, 2017) . In both environmental and clinical isolates, bla IMI-2 was usually found in transposable elements located in transferable plasmids (Aubron et al., 2005; Hopkins et al., 2017; Piedra-Carrasco et al., 2017; Rojo-Bezares et al., 2012; Rotova et al., 2017; Yu et al., 2006; Zhang et al., 2017) ; however, one E. asburiae clinical isolate carrying the bla IMI-2 gene in its chromosome (the transposable element was not characterized) was identified in South Africa in 2015 (Gqunta et al., 2015) . Our results show that this acquired carbapenemase gene is also spread outside of clinical and river environments, which may be related to the presence of bla IMI-2 in transposable elements located in transferable plasmids (Aubron et al., 2005; Hopkins et al., 2017; Piedra-Carrasco et al., 2017; Rojo-Bezares et al., 2012; Rotova et al., 2017; Yu et al., 2006; Zhang et al., 2017) . Further, surveillance is necessary to better characterize the role of freshwater environments as a source of IMI-2-producing E. asburiae, which can be both an opportunistic pathogen, as well as a reservoir of this transferable carbapenemase.
In conclusion, our findings show for the first time that freshwater environments in Los Angeles-Southern California represent an underappreciated reservoir of bacteria resistant to carbapenems and other antibiotics, many of which carry intrinsic or acquired carbapenemase genes. sequences.
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